Safety, tolerability and pharmacokinetics of the phosphodiesterase 2 inhibitor BI 474121: An overview of phase I randomized trials in healthy volunteers
Year: 2024
Type: article
Source: Journal of Psychopharmacology
Authors: Jennifer Schaible, Andreas Scholz, Rainer-Georg Goeldner, Norio Yamamura
Institutions: Boehringer Ingelheim (Germany), Boehringer Ingelheim (Japan)
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4402485489
